Finkielstein Vadim A MD is categorized under Doctors in Princeton Junction, NJ .
Finkielstein Vadim A MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Vadim Finkielstein at the company’s single location by writing to 88 Princeton Hightstown Road # 203, Princeton Junction, New Jersey NJ 08550 or by phoning (609) 750-7330. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Finkielstein Vadim A MD |
| Contact Person: | Vadim Finkielstein |
| Address: | 88 Princeton Hightstown Road # 203, Princeton Junction, New Jersey 08550 |
| Phone Number: | (609) 750-7330 |
| Website Address: | hypertension-nephrology.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Finkielstein Vadim A MD was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Vadim Finkielstein for inquiries that concern Finkielstein Vadim A MD by calling the company number (609) 750-7330, as your correspondence is most welcome. Additionally, the physical location of the single location of Finkielstein Vadim A MD can be found at the coordinates 40.3107,-74.61898 as well as the street address 88 Princeton Hightstown Road # 203 in Princeton Junction, New Jersey 08550.
For its online presence, you may visit Finkielstein Vadim A MD’s website at hypertension-nephrology.com and engage with its social media outlets through on Twitter and on Facebook.